This content is machine translated Chronic lymphocytic leukemia (CLL) One year of first-line therapy for CLL for the prospect of more than 5 years of treatment freedom¹ The BCL2 inhibitor venetoclax has been approved in Switzerland as a first-line therapy for chronic lymphocytic leukemia (CLL) since November 16, 2023 [2]. This is based on the results of…
View Post 2 min This content is machine translated Study report: Primary cutaneous lymphomas Skin-directed or systemic therapy? Diffuse large B-cell lymphoma is the most common malignant tumor of the lymphatic system. The primary objective of a retrospective clinical study led by Charité-Universitätsmedizin Berlin was to compare systemic…
View Post 11 min This content is machine translated Esophagus Therapy of esophageal carcinoma – an overview Esophageal carcinomas are comparatively rare tumors and account for approximately 1% of all malignancies worldwide. Based on their location, a distinction is made between cervical and intrathoracic tumors. Histologically, they… CME-Test
View Post 4 min This content is machine translated Risk stratification for Barrett's esophagus Pathology test beats human experts Low-grade dysplasia is associated with an increased risk of progression in Barrett’s esophagus, but the diagnosis of LGD is limited by considerable interobserver variability. Several studies have shown that the…
View Post 2 min This content is machine translated SCLC Small cell lung cancer in everyday therapy – an update Small cell lung carcinomas must be treated quickly – they usually grow rapidly and form metastases early on. The diagnosis is therefore often only made at an advanced stage. Lung…
View Post 7 min This content is machine translated Actinic keratosis Use topical preparations in good time It is not yet possible to predict which actinic keratoses (AK) will develop into invasive squamous cell carcinoma. It is therefore advisable to treat all AK lesions. If AK is…
View Post 11 min This content is machine translated Artificial intelligence in medicine Opportunities and risks of AI The concept of artificial intelligence dates back to the 1950s. 20th century and includes a collection of technologies that allow a computer to emulate typical characteristics of human intelligence. Initially,… CME-Test
View Post 9 min This content is machine translated Reactive plasmocytoses Polyclonal plasma cell proliferation in focus. Reactive plasmocytoses are rare, but then often pronounced. They must be differentiated from reactive (polyclonal) and monoclonal plasma cell proliferation. A precise differential diagnosis enables effective therapy. CME-Test
View Post 20 min This content is machine translated Head and Neck Tumors Current treatment options – an update Tumors of the head and neck were the seventh most common cancer worldwide in 2018. The most important risk factors include nicotine and alcohol consumption. The prognosis and multimodality treatment… CME-Test
View Post 3 min This content is machine translated Colonoscopy Effective bowel preparation with PEG solution Colorectal carcinoma is one of the most common malignant diseases worldwide. Colorectal cancer screenings play an important role in secondary prevention. Polyethylene glycol (PEG)-based solutions have been a proven means…
View Post 7 min This content is machine translated Hematology and medical oncology The world of hematology and oncology research The rapid technological developments in diagnostics and innovations in multimodal therapy in the field of hematology and medical oncology were the focus of the annual conference. While immunotherapies with monoclonal…
